Firm behind opioid addiction treatment drugs quits London Stock Exchange after moving primary to US last year
The drugmaker Indivior has become the latest company to abandon its listing in London, heaping further pressure on the London Stock Exchange (LSE) to reinvigorate itself.
The Virginia-based company, which makes the opioid addiction treatments Sublocade and Suboxone, switched its main stock listing to the US last year but now plans to cancel the secondary listing it had retained in London.
Firm behind opioid addiction treatment drugs quits London Stock Exchange after moving primary to US last yearBusiness live – latest updatesThe drugmaker Indivior has become the latest company to abandon its listing in London, heaping further pressure on the London Stock Exchange (LSE) to reinvigorate itself.The Virginia-based company, which makes the opioid addiction treatments Sublocade and Suboxone, switched its main stock listing to the US last year but now plans to cancel the secondary listing it had retained in London. Continue reading… London Stock Exchange, Pharmaceuticals industry, Business, Nasdaq, Stock markets, Opioids, Drugs, UK news, US news Business | The Guardian
